Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients

Author(s): Erro R, Santangelo G, Picillo M, Vitale C, Amboni M, et al.

Abstract

Little is known about the relationship between cognitive dysfunctions and the non-motor complex in subjects with newly diagnosed untreated Parkinson's disease (PD). The aim of this study was to explore the association between non-motor symptoms (NMS) and cognitive dysfunctions in an incident cohort of de novo, drug-naive, PD patients. Sixty-six non-demented, early, untreated PD patients completed a semi-structured interview on NMS and a battery of neuropsychological tests that assess verbal memory, visuospatial abilities, and attention/executive functions. Scores were age- and education-corrected. Patients who failed at least two tests for each cognitive domain were diagnosed as having mild cognitive impairment (MCI). All but three (95.4%) PD patients complained of at least one NMS. A total of 37.8% was diagnosed with MCI. There was a relationship between sleep-NMS and cognitive dysfunctions. Specifically, both REM behavioral sleep disorders (RBD) and insomnia were associated with lower scores on several cognitive tests. Moreover, RBD was closely related to MCI. NMS and MCI are very common even in the early phase of PD, before patients are treated. Given the correlation between sleep disturbances and cognitive impairment, it is possible that sleep symptoms in PD patients might be considered as an early marker of dementia.

Similar Articles

A survey of pain in idiopathic Parkinson's disease

Author(s): Lee MA, Walker RW, Hildreth TJ, Prentice WM

Depression and pain comorbidity: a literature review

Author(s): Bair MJ, Robinson RL, Katon W, Kroenke K

Pain is common in Parkinson's disease

Author(s): Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M

Low dopamine D(2) receptor binding potential in social phobia

Author(s): Schneier FR, Liebowitz MR, Abi-Dargham A, Zea-Ponce Y, Lin SH, et al.

Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD--a comparison of neuropsychological effects

Author(s): Smeding HM, Esselink RA, Schmand B, Koning-Haanstra M, Nijhuis I, et al.

Pain in Parkinson's disease

Author(s): Ford B

CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice

Author(s): Airavaara M, Harvey BK, Voutilainen MH, Shen H, Chou J, et al.

Pain in Parkinson's disease

Author(s): Ha AD, Jankovic J

Pain sensitivity and clinical progression in Parkinson's disease

Author(s): Mylius V, Brebbermann J, Dohmann H, Engau I, Oertel WH, et al.

Validation of the non-motor symptoms questionnaire (NMS-Quest)

Author(s): Romenets SR, Wolfson C, Galatas C, Pelletier A, Altman R, et al.